Enzo Health, a home health and post-acute care startup founded in 2024, has raised $20 million in Series A funding, bringing its total to $26 million. The round was led by N47, with backing from existing investors including Gradient, Tandem Ventures and Rigby Watts. The company has developed an AI-powered platform designed to help home health agencies manage increasingly complex administrative and regulatory demands by analyzing clinical documentation for reimbursement and compliance, recommending referrals based on coverage criteria, and validating OASIS data to reduce denials, audit risk and costly corrections.
The new funding will be used to expand Enzo Health’s capabilities beyond home health into skilled nursing facilities and hospice care, areas facing similar operational strain. As the population ages rapidly, providers are under growing pressure from rising demand, tighter regulations and workforce challenges, often leading to clinician burnout and high turnover. Enzo Health aims to address these issues by streamlining workflows and improving operational efficiency, allowing care teams to spend more time with patients and less on administrative tasks.
This investment comes amid broader momentum in the senior care and home-based healthcare market, driven by the “silver tsunami,” with thousands of people turning 65 each day. Other companies, such as Sage and The Helper Bees, are also attracting funding to build technology platforms that support aging populations and enable independent living. Enzo Health’s focus on AI-driven automation and compliance positions it within this growing segment, targeting both scalability and the need for more sustainable care delivery models.
Click here to read the original news story.
